Bone disease in primary hypercalciuria

Clinical Cases in Mineral and Bone Metabolism

Volumn 5, Issue 2, 2008, Pages 118-126

  Sella, Stefania ^a,b   Cattelan, Catia ^a   Realdi, Giuseppe ^a   Giannini, Sandro ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Bone density; Intestinal calcium absorption; Osteoporosis; Phosphate metabolism; Primary hypercalciuria

Indexed keywords

CALCIUM; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

BONE DEMINERALIZATION; BONE DENSITY; BONE DISEASE; BONE METABOLISM; CALCIUM ABSORPTION; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; DEMINERALIZATION; DISEASE COURSE; FRAGILITY FRACTURE; HUMAN; HYPERCALCIURIA; INTESTINE; KIDNEY TUBULE; MORPHOMETRICS; NEPHROLITHIASIS; OSTEOLYSIS; PROTEIN INTAKE; SHORT SURVEY;

EID: 57149121718     PISSN: 17248914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (74)

1. Abright F, Henneman P, Benedict PH, et al. Idiopathic hypercalciuria: a preliminary report. Proc R Soc Med. 1953;46:1077-1081.
2. Hodgkinson A, Pyrah LN. The urinary excretion of calcium and inorganic phosphate in 344 patients with calcium stone of renal origin. Br J Surg. 1958;46:10-18.
3. Smith LH, VanDenBerg CJ, Wilson DM. Nutrition and urolithiasis. N Engl J Med. 1980;98:87-89.
4. Pak CY. Medical management of nephrolithiasis. J Urol. 1982;128:1157-1164.
5. Pak CY, Ohata M, Lawrence EC, et al. The hypercalciurias: causes, parathyroid functions, and diagnostic criteria. J Clin Invest. 1974;54:387-400.
6. Heaney RP, Recker RR, Ryan RA. Urinary calcium in perimenopausal women: normative values. Osteoporos Int. 1999;9:13-18.
7. Kerstetter JE, O'Brian KO, Insogna KL. Low protein intake: the impact on calcium and bone homeostasis in humans. J Nutr. 2003;133:855S-861S.
8. Nordin BE, Need AG, Morris HA, et al. The nature and significance of the relationship between urinary sodium and urinary calcium in women. J Nutr. 1993;123:1615-1622.
9. Hegsted M, Schuette SA, Zemel MB, et al. Urinary calcium and calcium balance in young men as affected by level of protein and phosphorus intake. J Nutr. 1981;111:553-562.
10. Zemel MB. Calcium utilization: effect of varying level and source of dietary protein. Am J Clin Nutr. 1988;48:880-883.
11. Kerstetter JE, O'Brien KO, Insogna KL. Dietary protein, calcium metabolism, and skeletal homeostasis revisited. Am J Clin Nutr. 2003;78:584S-592S.
12. Pak CY, Britton F, Peterson R, et al. Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria. Am J Med. 1980;69:19-30.
13. Vezzoli G, Tanini A, Ferrucci L, et al. Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. J Am Soc Nephrol. 2002;13:2517-2523.
14. Broadus AE, Insogna KL, Lang R, et al. Evidence for disordered control of 1,25-dihydroxyvitamin D production in absorptive hypercalciuria. N Engl J Med. 1984;311:73-80.
15. Li XQ, Tembe V, Horwitz GM, et al. Increased intestinal vitamin D receptor in genetic hypercalciuric rats. A cause of intestinal calcium hyperabsorption. J Clin Invest. 1993;91:661-667.
16. Zerwekh JE, Reed BY, Heller HJ, et al. Normal vitamin D receptor concentration and responsiveness to 1, 25-dihydroxyvitamin D3 in skin fibroblasts from patients with absorptive hypercalciuria. Miner Electrolyte Metab. 1998;24:307-313.
17. Prié D, Ravery V, Boccon-Gibod L, et al. Frequency of renal phosphate leak among patients with calcium nephrolithiasis. Kidney Int. 2001;60:272-276.
18. Bushinsky DA. Genetic hypercalciuric stone-forming rats. Curr Opin Nephrol Hypertens. 1999;8:479-88.
19. Bataille P, Fardellone P, Ghazali A, et al. Pathophysiology and treatment of idiopathic hypercalciuria. Curr Opin Rheumatol. 1998;10:373-388.
20. Levy FL, Adams-Huet B, Pak CYC. Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med. 1998;98:50-59.
21. Weisinger JR. New insights in the pathogenesis of idiopathic hypercalciuria; the role of bone. Kidney Int. 1996;49:1507-1518.
22. Lawoyin S, Sismilich S, Browne R, et al. Bone mineral content in patients with calcium urolithiasis. Metabolism. 1979;28:1250-1254.
23. Fuss M, Gillet C, Simon J, et al. Bone mineral content in idiopathic renal stone disease and in primary hyperparathyroidism. Eur Urol. 1983;9:32-34.
24. Pacifici R, Rothstein M, Rifas L, et al. Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria. J Clin Endocrinol Metab. 1990;71:138-145.
25. Bataille P, Achard JM, Fournier A, et al. Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers. Kidney Int. 1991;39:1193-1205.
26. Borghi L, Meschi T, Guerra A, et al. Vertebral mineral content in diet-dependent and diet-independent hypercalciuria. J Urol. 1991;146:1334-1338.
27. Pietschmann F, Breslau NA, Pak CY. Reduced vertebral bone density in hypercalciuric nephrolithiasis. J Bone Miner Res. 1992;12:1383-1388.
28. Jaeger P, Lippuner K, Casez JP, et al. Low bone mass in idiopathic renal stone formers: magnitude and significance. J Bone Miner Res. 1994;10:1525-1532.
29. Weisinger JR, Alonzo E, Bellorin-Font E, et al. Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria. Kidney Int. 1996;49:244-250.
30. Ghazali A, Fuentes V, Desaint C, et al. Low bone mineral density and peripheral blood monocyte activation profile in calcium stone formers with idiopathic hypercalciuria. J Clin Endocrinol Metab. 1997;82:32-38.
31. Giannini S, Nobile M, Sartori L, et al. Bone density and skeletal metabolism are altered in idiopathic hypercalciuria. Clinical Nephrology. 1998;50:94-100.
32. Misael da Silva AM, dos Reis LM, Pereira RC, et al. Bone involvement in idiopathic hypercalciuria. Clin Nephrol. 2002;57:183-191.
33. Tasca A, Cacciola A, Ferrarese P, et al. Bone alterations in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Urology. 2002;59:865-869.
34. Asplin JR, Bauer KA, Kinder J, et al. Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis. Kidney Int. 2003;63:662-669.
35. Vezzoli G, Rubinacci A, Bianchin C, et al. Intestinal calcium absorption is associated with bone mass in stone-forming women with idiopathic hypercalciuria. Am J Kidney Dis. 2003;42:1177-1183.
36. Caudarella R, Vescini F, Buffa A. Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors. J Nephrol. 2003;16:260-266.
37. Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int. 1994;4:368-381.
38. Melton LJ III, Crowson CS, Khosla S, et al. Fracture risk among patients with urolithiasis: a population-based cohort study. Kidney Int. 1998,53:459-464.
39. Lauderdale DS, Thisted RA, Wen M, et al. Bone Mineral Density and fracture among prevalent kidney stone cases in the Third National Health and Nutrition Examination Survey. J Bone Miner Res. 2001;16:1893-1898.
40. Heilberg IP, Martini LA, Szejnfeld VL. Bone disease in calcium stone forming patients. Clin Nephrol. 1994;42:175-182.
41. Bordier P, Rychewart A, Gueris J, et al. On the pathogenesis of so-called idiopathic hypercalciuria. Am J Med.1977;63:398-409.
42. Steiniche T, Mosekilde L, Christensen MS, et al. A histomorphometric determination of iliac bone remodeling in patients with recurrent renal stone formation and idiopathic hypercalciuria. Acta Pathol Microbiol Immunol Scand. 1989;97:309-316.
43. Malluche HH, Tschoepe W, Ritz E, et al. Abnormal bone histology in idiopathic hypercalciuria. J Clin Endocrinol Metab. 1980;50:654-658.
44. Thomas J, Roujean J, Aboulker P. Les lésions osseuses dans la lithiase rénale. Leur étude par examen histologique d'un fragment costal. Presse Med. 1962;70: 2437-2440.
45. Zerwekh JE, Sakhaee K, Breslau NA, et al. Impaired bone formation in male idiopathic osteoporosis: further reduction in the presence of concomitant hypercalciuria. Osteoporos Int. 1992;2:128-134.
46. Satton RAL, Walker VR. Bone resorption and hypercalciuria in calcium stone formers. Metabolism. 1986;35:485-488.
47. Barkin J, Wilson DR, Manuel MA, et al. Bone mineral content in idiopathic calcium nephrolithiasis. Miner Electrolyte Metab. 1985;11:19-24.
48. Feskanich D, Willett WC, Stampfer MJ, et al. A prospective study of thiazide use and fractures in women. Osteoporos Int. 1997;7:79-84.
49. LaCroix AZ, Wienpahl J, White LR, et al. Thiazide diuretic agents and the incidence of hip fracture. New Engl J Med. 1990;322:286-290.
50. Nguyen TV, Eisman JA, Kelly PJ, et al. Risk factors for osteoporotic fractures in elderly men. Am J Epidemiol. 1996;144:255-263.
51. Cauley JA, Cummings SR, Seeley DG, et al. Effects of thiazide diuretic therapy on bone mass, fractures and falls. The Study of Osteoporotic Fractures Research Group. Ann Intern Med. 1993;118:666-673.
52. Felson DT, Sloutskis D, Anderson JJ, et al. Thiazide diuretics and the risk of hip fracture. Results from the Framingham Study. JAMA. 1991;265:370-373.
53. Schoofs MWJC, van der Klift M, Hofman A, et al. Thiazide diuretics and the risk for hip fracture. Ann Intern Med. 2003;16:476-482.
54. Adams JS, Song CF, Kantorovich V. Rapid recovery of bone mass in hypercalciuric, osteoporotic man treated with hydrochlorothiazide. Ann Intern Med. 1999;130:658-660.
55. Reid IR, Ames RW, Orr-Walker BJ, et al. Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial. Am J Med. 2000;109:362-370.
56. LaCroix AZ, Ott SM, Ichikawa L, et al. Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2000;133:516-526.
57. Gowen M, Mundy GR. Actions of recombinant interleukin 1, interleukin 2 and interferon-gamma on bone resorption in vitro. J Immunol. 1986;136:2478-2482.
58. Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. 2000;21:115-137.
59. Cohen-Solal ME, Graulet AM, Gueris J, et al. Bone resorption at the femoral neck is dependent on local factors in non osteoporotic late postmenopausal women: an in vivo-in vitro study. J Bone Miner Res. 1995;10:307-315.
60. Chen WC, Wu HC, Chen HY, et al. Interleukin-1beta gene and receptor antagonist gene polymorphisms in patients with calcium oxalate stones. Urol Res. 2001;29: 321-324. 61. Giannini S, Nobile M, Sartori L, et al. Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Am J Clin Nutr. 1999;9:267-271.
61. Maierhofer WJ, Gray RW, Cheung HS, et al. Bone resorption stimulated by elevated serum 1,25 (OH)2- vitamin D concentrations in healthy men. Kidney Int. 1983;24: 555-560.
62. Frick KK, Bushinsky DA. Molecular mechanisms of primary hypercalciuria. J Am Soc Nephrol. 2003;14:1082-1095.
63. Fuss M, Pepersack T, Bergman P, et al. Low calcium diet in idiopathic urolithiasis: a risk factor for osteopenia as great as in primary hyperparathyroidism. Br J Urol. 1990;65:560-563.
64. Hess B. Low calcium diet in hypercalciuric calcium nephrolithiasis: first do not harm. Scanning Microsc. 1996;10:547-554.
65. Curhan GC, Willett WC, Rimm EB, et al. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993;328:833-838.
66. Williams CP, Child DF, Hudson PR, et al. Inappropriate phosphate excretion in idiopathic hypercalciuria: the key to a common cause and future treatment? J Clin Pathol. 1996;49:881-888.
67. Prié D, Ravery V, Boccon-Gibod L, et al. Frequency of renal phosphate leak among patients with calcium nephrolithiasis. Kidney Int. 2001;60:272-276.
68. Tieder M, Modai D, Shaked U, et al. "Idiopathic" hypercalciuria and hereditary hypophosphatemic rickets. Two phenotypical expressions of a common genetic defect. New Engl J Med. 1987;316:125-129.
69. Prié D, Huart V, Bakouh N, et al. Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter. New Engl J Med. 2002;347:983-991.
70. Tannenbaum C, Clark J, Schwartzman K, et al. Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab. 2002;87:4431-4437.
71. Deutschmann HA, Weger M, Weger W, et al. Search for occult secondary osteoporosis: impact of identified possible risk factors on bone mineral density. J Intern Med. 2002;252:389-397.
72. Peris P, Guanabens N, Martinez de Osaba MJ, et al. Clinical characteristics and etiologic factors of premenopausal osteoporosis in a group of Spanish women. Semin Arthritis Rheum. 2002;32:64-70.
73. Giannini S, Nobile M, Dalle Carbonare L, et al. Hypercalciuria is a common and important finding in postmenopausal women with osteoporosis. Eur J Endocrinol. 2003;149:209-213.
74. Heshmati HM, Khosla S, Burritt MF, et al. A defect in renal calcium conservation may contribute to the pathogenesis of postmenopausal osteoporosis. J Clin Endocrinol Metab. 1998;83: 1916-1920